Cost-Effectiveness Analysis of Positive Airway Pressure in Patient with Obstructive Sleep Apnea

Hansol Kim, J. K. Kim, J. Cho
{"title":"Cost-Effectiveness Analysis of Positive Airway Pressure in Patient with Obstructive Sleep Apnea","authors":"Hansol Kim, J. K. Kim, J. Cho","doi":"10.18787/jr.2021.00357","DOIUrl":null,"url":null,"abstract":"Background and Objectives: Positive airway pressure (PAP) is effective at reducing the number of complications in patients with obstructive sleep apnea (OSA). To the best of our knowledge, no cost-effectiveness analysis of PAP has been conducted in Korea. Subjects and Method: We classified subjects into two groups, those with moderate-to-severe OSA who used PAP after polysomnography (PAP treatment group) and those who did not receive a diagnosis and treatment (control group), and compared their medical expenses over a period of 10 years. The incidence rate of common complications and accidents (coronary heart disease, heart failure, stroke, depression, diabetes, vehicular accidents, and work-related accidents) with or without PAP was adopted through a literature review. The average medical expenses for treating each complication and accident were found by searching several databases. The analysis consisted of a payer’s perspective and a societal perspective. Results: The incidence of all complications was higher in the control group than in the PAP treatment group. However, since the absolute incidence rate was not high in either group and medical expenses in Korea are low, the expected treatment cost was not high. In contrast, the PAP rental fee was relatively high. To obtain 1 unit of disability-adjusted life year, it costs 40,873,288 won from the payer’s perspective and 31,791,810 won from the societal perspective. Conclusion: PAP treatment reduces patient complications and extends their lifespan, but costs must be considered.","PeriodicalId":33935,"journal":{"name":"Journal of Rhinology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rhinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18787/jr.2021.00357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Objectives: Positive airway pressure (PAP) is effective at reducing the number of complications in patients with obstructive sleep apnea (OSA). To the best of our knowledge, no cost-effectiveness analysis of PAP has been conducted in Korea. Subjects and Method: We classified subjects into two groups, those with moderate-to-severe OSA who used PAP after polysomnography (PAP treatment group) and those who did not receive a diagnosis and treatment (control group), and compared their medical expenses over a period of 10 years. The incidence rate of common complications and accidents (coronary heart disease, heart failure, stroke, depression, diabetes, vehicular accidents, and work-related accidents) with or without PAP was adopted through a literature review. The average medical expenses for treating each complication and accident were found by searching several databases. The analysis consisted of a payer’s perspective and a societal perspective. Results: The incidence of all complications was higher in the control group than in the PAP treatment group. However, since the absolute incidence rate was not high in either group and medical expenses in Korea are low, the expected treatment cost was not high. In contrast, the PAP rental fee was relatively high. To obtain 1 unit of disability-adjusted life year, it costs 40,873,288 won from the payer’s perspective and 31,791,810 won from the societal perspective. Conclusion: PAP treatment reduces patient complications and extends their lifespan, but costs must be considered.
阻塞性睡眠呼吸暂停患者气道正压治疗的成本-效果分析
背景和目的:气道正压通气(PAP)可有效减少阻塞性睡眠呼吸暂停(OSA)患者的并发症。据我们所知,韩国尚未对PAP进行成本效益分析。受试者和方法:我们将受试者分为两组,即多导睡眠图检查后使用PAP的中重度OSA患者(PAP治疗组)和未接受诊断和治疗的患者(对照组),并比较他们在10年内的医疗费用。通过文献回顾,采用有或无PAP的常见并发症和事故(冠心病、心力衰竭、中风、抑郁症、糖尿病、交通事故和工伤事故)的发生率。通过搜索多个数据库,可以找到治疗每种并发症和事故的平均医疗费用。分析包括付款人视角和社会视角。结果:对照组所有并发症的发生率均高于PAP治疗组。然而,由于两组患者的绝对发病率都不高,而且韩国的医疗费用也很低,因此预期的治疗费用并不高。相比之下,PAP的租金相对较高。从付款人的角度来看,获得1个单位的残疾调整生命年需要花费40873288韩元,从社会角度来看需要花费31791810韩元。结论:PAP治疗可以减少患者并发症,延长患者寿命,但必须考虑费用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
23
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信